Page last updated: 2024-08-26

sr 2555 and EHS Tumor

sr 2555 has been researched along with EHS Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, DM; Brown, JM; Lee, WW; Yu, NY1
Siemann, DW1

Other Studies

2 other study(ies) available for sr 2555 and EHS Tumor

ArticleYear
SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
    International journal of radiation oncology, biology, physics, 1981, Volume: 7, Issue:6

    Topics: Animals; Carcinoma; Cell Line; Central Nervous System; Cricetinae; Dogs; Etanidazole; Female; In Vitro Techniques; Lipid Metabolism; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; X-Rays

1981
Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    British journal of cancer, 1982, Volume: 45, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etanidazole; Female; Leukocyte Count; Lomustine; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Radiation-Sensitizing Agents; Sarcoma, Experimental

1982